Dr. John M. Hill has been appointed as Chair, Integrated Site Network for Accel Research Sites (ARS). With more than 15 years of experience in clinical research, Dr. Hill is board-certified by the American Board of Family Medicine and has earned certification as a Certified Principal Investigator from the Association of Clinical Research Professionals.
In this new role, Dr. Hill will join existing ARS clinical leaders Dr. Bruce Rankin, Medical Director, DeLand Clinical Research Unit and Dr. Hayes Williams, Medical Director, Birmingham Clinical Research Unit.
Who is Accel Research Sites?
Based in Florida and Alabama, Accel Research is a multi-therapeutic network of clinical research sites dedicated to the expert delivery of treatment options to patients through their local providers. They partner with the most innovative and significant pharmaceutical, biotechnology and medical device companies in the world to advance healthcare and wellness in the communities they serve.
They provide a full range of clinical trial services in a wide range of therapeutic indications, conducting Phase I, in-house hospital, vaccine and outpatient phase II-IV trials. They emphasize
Accel recently appointed a new CRO, Matthew Maxwell, as Chief Executive Officer (CEO). Mr. Maxwell had over 12 years of experience in clinical research leadership and most recently, served as Chief Operating Officer of ARS.